Hsiu Wu

723 total citations · 1 hit paper
13 papers, 431 citations indexed

About

Hsiu Wu is a scholar working on General Health Professions, Applied Microbiology and Biotechnology and Infectious Diseases. According to data from OpenAlex, Hsiu Wu has authored 13 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in General Health Professions, 6 papers in Applied Microbiology and Biotechnology and 5 papers in Infectious Diseases. Recurrent topics in Hsiu Wu's work include Antibiotic Use and Resistance (6 papers), Bacterial Identification and Susceptibility Testing (4 papers) and HIV/AIDS Research and Interventions (2 papers). Hsiu Wu is often cited by papers focused on Antibiotic Use and Resistance (6 papers), Bacterial Identification and Susceptibility Testing (4 papers) and HIV/AIDS Research and Interventions (2 papers). Hsiu Wu collaborates with scholars based in United States, Uganda and Kenya. Hsiu Wu's co-authors include Minn Soe, Ya-Lin A. Huang, Maria C.B. Mendoza, Dawn K. Smith, Karen W. Hoover, Jonathan R. Edwards, Daniel S. Budnitz, Andrea L. Benin, Heather Dubendris and Suparna Bagchi and has published in prestigious journals such as Clinical Infectious Diseases, MMWR Morbidity and Mortality Weekly Report and Infection Control and Hospital Epidemiology.

In The Last Decade

Hsiu Wu

12 papers receiving 427 citations

Hit Papers

Effectiveness of Pfizer-BioNTech and Moderna Vaccines in ... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021
    2021 189 citations Srinivas Nanduri, Tamara Pilishvili et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsiu Wu United States 7 317 126 121 79 75 13 431
Fifonsi Adjidossi Gbeasor‐Komlanvi Togo 11 150 0.5× 167 1.3× 104 0.9× 29 0.4× 46 0.6× 52 423
Shirin Aliabadi United Kingdom 6 315 1.0× 46 0.4× 52 0.4× 80 1.0× 73 1.0× 12 541
François Bénézit France 10 174 0.5× 95 0.8× 115 1.0× 39 0.5× 20 0.3× 19 333
Kevin R. Clarke United States 9 257 0.8× 73 0.6× 58 0.5× 46 0.6× 50 0.7× 15 443
Olatunji Adetokunboh South Africa 11 272 0.9× 137 1.1× 76 0.6× 43 0.5× 103 1.4× 37 413
Kevin O’Callaghan United States 10 174 0.5× 85 0.7× 163 1.3× 39 0.5× 21 0.3× 22 441
Emma Byström Sweden 8 79 0.2× 118 0.9× 125 1.0× 21 0.3× 31 0.4× 14 502
Ibukunoluwa Akinboyo United States 11 184 0.6× 84 0.7× 32 0.3× 96 1.2× 42 0.6× 31 451
Ammar Ali Saleh Jaber United Arab Emirates 10 176 0.6× 115 0.9× 42 0.3× 12 0.2× 28 0.4× 43 323
Martin Kouame Tchankoni Togo 8 107 0.3× 47 0.4× 44 0.4× 24 0.3× 33 0.4× 33 240

Countries citing papers authored by Hsiu Wu

Since Specialization
Citations

This map shows the geographic impact of Hsiu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsiu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsiu Wu more than expected).

Fields of papers citing papers by Hsiu Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsiu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsiu Wu. The network helps show where Hsiu Wu may publish in the future.

Co-authorship network of co-authors of Hsiu Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Hsiu Wu. A scholar is included among the top collaborators of Hsiu Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsiu Wu. Hsiu Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
O’Leary, Erin, Melinda M. Neuhauser, Arjun Srinivasan, et al.. (2023). Impact of the COVID-19 Pandemic on Inpatient Antibiotic Use in the United States, January 2019 Through July 2022. Clinical Infectious Diseases. 78(1). 24–26. 7 indexed citations
2.
Wu, Hsiu, Joseph D. Lutgring, L. Clifford McDonald, et al.. (2023). Selective and Cascade Reporting of Antimicrobial Susceptibility Testing Results and Its Impact on Antimicrobial Resistance Surveillance—National Healthcare Safety Network, April 2020 to March 2021. Microbiology Spectrum. 11(2). e0164622–e0164622. 5 indexed citations
3.
Geller, Andrew I., Daniel S. Budnitz, Heather Dubendris, et al.. (2022). Surveillance of COVID-19 Vaccination in Nursing Homes, United States, December 2020–July 2021. Public Health Reports. 137(2). 239–243. 6 indexed citations
4.
Xu, Kerui, Hsiu Wu, Qunna Li, et al.. (2022). Association between prevalence of laboratory-identified Clostridioides difficile infection (CDI) and antibiotic treatment for CDI in US acute-care hospitals, 2019. Infection Control and Hospital Epidemiology. 43(12). 1847–1852. 1 indexed citations
5.
Weiner, Lindsey M., Kathryn A. Haass, Cindy Gross, et al.. (2022). Pathogens attributed to central-line–associated bloodstream infections in US acute-care hospitals during the first year of the coronavirus disease 2019 (COVID-19) pandemic. Infection Control and Hospital Epidemiology. 44(4). 651–654. 4 indexed citations
6.
Wu, Hsiu, Minn Soe, Rebecca Konnor, et al.. (2021). Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27–July 14, 2020. Infection Control and Hospital Epidemiology. 43(10). 1473–1476. 37 indexed citations
7.
Lee, James T., Sandy Althomsons, Hsiu Wu, et al.. (2021). Disparities in COVID-19 Vaccination Coverage Among Health Care Personnel Working in Long-Term Care Facilities, by Job Category, National Healthcare Safety Network — United States, March 2021. MMWR Morbidity and Mortality Weekly Report. 70(30). 1036–1039. 50 indexed citations
8.
Nanduri, Srinivas, Tamara Pilishvili, Gordana Derado, et al.. (2021). Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021. MMWR Morbidity and Mortality Weekly Report. 70(34). 1163–1166. 189 indexed citations breakdown →
9.
Zhou, Liang, Hsiu Wu, Minn Soe, Daniel A. Pollock, & Jonathan Edwards. (2020). Risk Factors Associated With Hospital-Onset MRSA Proportion—National Healthcare Safety Network, 2017–2018. Infection Control and Hospital Epidemiology. 41(S1). s375–s376. 2 indexed citations
10.
O’Leary, Erin, Jonathan R. Edwards, Arjun Srinivasan, et al.. (2020). National Healthcare Safety Network Standardized Antimicrobial Administration Ratios (SAARs): A Progress Report and Risk Modeling Update Using 2017 Data. Clinical Infectious Diseases. 71(10). e702–e709. 22 indexed citations
11.
Wu, Hsiu, Amy Webb, Erin O’Leary, et al.. (2018). 1861. National Healthcare Safety Network’s Electronic Antimicrobial Use and Resistance Surveillance: First Cohort of Hospital Reporters, 2011–2017. Open Forum Infectious Diseases. 5(suppl_1). S531–S532.
12.
Wu, Hsiu, et al.. (2016). Uptake of HIV Preexposure Prophylaxis Among Commercially Insured Persons—United States, 2010–2014. Clinical Infectious Diseases. 64(2). 144–149. 104 indexed citations
13.
Wu, Hsiu, Lisa Hightow‐Weidman, Cynthia L. Gay, et al.. (2015). Unreported Male Sex Partners Among Men with Newly Diagnosed HIV Infection — North Carolina, 2011–2013. MMWR Morbidity and Mortality Weekly Report. 64(37). 1037–1041. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fifonsi Adjidossi Gbeasor‐Komlanvi Breakdown of academic impact, for papers by Shirin Aliabadi Breakdown of academic impact, for papers by François Bénézit Breakdown of academic impact, for papers by Kevin R. Clarke Breakdown of academic impact, for papers by Olatunji Adetokunboh Breakdown of academic impact, for papers by Kevin O’Callaghan Breakdown of academic impact, for papers by Emma Byström Breakdown of academic impact, for papers by Ibukunoluwa Akinboyo Breakdown of academic impact, for papers by Ammar Ali Saleh Jaber Breakdown of academic impact, for papers by Martin Kouame Tchankoni
Rankless by CCL
2026